Journal of Cardiovascular Computed Tomography
Volume 3, Issue 3 , Pages 161-167, May 2009

Hemodynamic and functional assessment of mechanical aortic valves using combined echocardiography and multidetector computed tomography

  • Troy M. LaBounty, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, Weill Cornell Medical College, 520 East 70th Street, Starr Pavilion 4th Floor, New York, NY 1002, USA
    • Corresponding Author InformationCorresponding author.
  • ,
  • Prachi P. Agarwal, MD

      Affiliations

    • Department of Radiology, Division of Cardiothoracic Radiology, University of Michigan Health System, Ann Arbor, MI, USA
  • ,
  • Aamer Chughtai, MBBS, MSc

      Affiliations

    • Department of Radiology, Division of Cardiothoracic Radiology, University of Michigan Health System, Ann Arbor, MI, USA
  • ,
  • Ella A. Kazerooni, MD, MS

      Affiliations

    • Department of Radiology, Division of Cardiothoracic Radiology, University of Michigan Health System, Ann Arbor, MI, USA
  • ,
  • Eric Wizauer

      Affiliations

    • Department of Radiology, Division of Cardiothoracic Radiology, University of Michigan Health System, Ann Arbor, MI, USA
  • ,
  • David S. Bach, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA

Received 30 December 2008; accepted 25 March 2009. published online 01 April 2009.

Background

Limitations are found in the ability of transthoracic echocardiography to evaluate mechanical aortic valve replacements (AVR). We evaluated the ability of combined echocardiography and computed tomography (CT) to enhance the hemodynamic and functional evaluation of AVR.

Methods

We performed a retrospective evaluation of 41 consecutive patients with AVR (27 bileaflet, 14 single disc) and both transthoracic echocardiography and 64-detector electrocardiographic-gated CT. Each study was interpreted by 2 independent, blinded readers. The effective orifice area was compared with the corrected energy-loss coefficient area and the geometric orifice area. Patients with an elevated mean pressure gradient (>15mm Hg) were assessed for potential abnormal findings, including patient–prosthesis mismatch, elevated cardiac index, valve dysfunction, significant regurgitation, or pressure recovery effect.

Results

Significant differences (P<0.05) and moderate-to-high correlations (r=0.55–0.98) were observed between the effective orifice area (2.2±0.8cm2), corrected energy-loss coefficient area (3.0±1.5cm2), and geometric orifice area (3.6±0.9cm2). At least one abnormality was observed in 7 of 25 patients with normal gradients and in 14 of 16 patients with elevated gradients (P<0.001). In 16 patients with elevated mean pressure gradient, a potential cause could be determined in 4 with echocardiography alone and in 14 patients with combined echocardiography and CT (P=0.001).

Conclusion

CT aids in the interrogation of prosthetic valve function, enhancing evaluation for patient prosthesis mismatch, and correction for pressure recovery by the corrected energy-loss coefficient. CT is additive to the assessment of mechanical AVR with transthoracic echocardiography, and the combination permits a more complete assessment of both AVR function and hemodynamics.

Keywords: Aortic valve, Echocardiography, Heart valve disease, Heart valve prosthesis, Spiral computed tomography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of interest: Dr. Bach has received research support from Edwards Lifesciences; Medtronic, Inc; and St. Jude Medical, Inc. He serves as a consultant to CVRx; Edwards Lifesciences; Medtronic, Inc; and St. Jude Medical, Inc. Dr. Kazerooni receives support from GE Medical. She is on the board of directors for GERRAF. All other authors have no external sources of financial support and have no conflicts of interest to report.

 These data, in part, were presented in abstract form at the American Heart Association 2008 Scientific Sessions in New Orleans, LA, November 10, 2008.

PII: S1934-5925(09)00147-6

doi:10.1016/j.jcct.2009.03.006

Journal of Cardiovascular Computed Tomography
Volume 3, Issue 3 , Pages 161-167, May 2009